Status:
COMPLETED
Effect of Prevnar 13 on Ear Infections in Children
Lead Sponsor:
Pfizer
Conditions:
Otitis Media
Eligibility:
All Genders
6-30 years
Brief Summary
Prevnar (7 valent pneumococcal conjugate vaccine \[7vPnC\]) has been shown to be effective against ear infections in children. Prevnar 13 is a new vaccine that is similar to Prevnar. It is expected th...
Detailed Description
Infants who have completed the Prevnar 13 infant vaccination series who provide consent and fit the study inclusion criteria to participate in the study will be recruited.
Eligibility Criteria
Inclusion
- Subject has received full (3-dose) infant series of Prevnar 13
Exclusion
- Prior vaccination with any 7vPnC.
- Prior vaccination with 23-valent pneumococcal polysaccharide vaccine (23vPS).
- Any major illness/condition that, in the investigator's judgment, will substantially increase the risk associated with the subject's participation in the study.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT01199016
Start Date
September 1 2010
End Date
January 1 2016
Last Update
March 1 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Penfield Pediatrics
Penfield, New York, United States, 14526
2
Long Pond Pediatrics
Rochester, New York, United States, 14606
3
Legacy Pediatrics
Rochester, New York, United States, 14618
4
Lewis Pediatrics
Rochester, New York, United States, 14618